Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6662799

CC(C)Cc1ccccc1OC(C)OC(C)[N+](C)(C)Cc1ccccc1.[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 3/20 0.32
SLC6A3 known ✓ Q01959 1/20 0.32
CHRM2 known ✓ P08172 1/20 0.31
CHRM1 known ✓ P11229 1/20 0.31
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAOA P21397 2/20 0.34
MAOB P27338 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34
PTGER1 P34995 1/20 0.32
PTGER4 P35408 1/20 0.32
PTGER3 P43115 1/20 0.32
PTGER2 P43116 1/20 0.32
SLC6A4 P31645 2/20 0.32
KCNH2 Q12809 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25349713 0.99 GABRA1 (0.35) KDM4EALDH1A1TDP1MAOAMAOB
Hydrochloric Acid SCHEMBL56683 0.91 KDM4E (0.33) KDM4EALDH1A1TDP1MAOAMAOB
Water SCHEMBL9229151 0.90 KDM4E (0.33) KDM4EALDH1A1TDP1MAOAMAOB
SCHEMBL5360957 0.90 GABRA1 (0.33) KDM4EALDH1A1TDP1MAOAGABRA1
Hydrochloric Acid SCHEMBL252557 0.82 MEN1 (0.45) MEN1KMT2ATP53MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL3695293 0.81 ACHE (0.36) GABRA1GABRB2SLC6A2SLC6A4KCNH2
SCHEMBL6524582 0.81 DNM1 (0.44) MEN1KMT2ATP53MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL8958601 0.81 KDM4E (0.37) KDM4EALDH1A1TDP1MAOAMAOB
Hydrochloric Acid SCHEMBL11139244 0.79 KDM4E (0.43) KDM4EALDH1A1TDP1MAOASLC6A2
SCHEMBL1013749 0.79 GABRA1 (0.36) KDM4EALDH1A1TDP1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3648733-B1 TOPICAL COMPOSITIONS DSM IP ASSETS BV (NL) 2025-08-06 EP disclosed
EP-3709954-B1 TOPICAL COMPOSITIONS OF PHYTANTRIOL AND P-HYDROXYACETOPHENONE DSM IP ASSETS BV (NL) 2025-02-26 EP disclosed
EP-3965721-B1 TOPICAL COMPOSITIONS WITH ANTIMICROBIAL AGENT MIXTURE DSM IP ASSETS BV (NL) 2023-06-14 EP disclosed
US-20220296480-A1 TOPICAL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2022-09-22 US disclosed
US-20220211594-A1 TOPICAL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2022-07-07 US disclosed
US-11364208-B2 Topical compositions DSM IP ASSETS B.V. (NL) 2022-06-21 US disclosed
US-11324680-B2 Topical compositions DSM IP ASSETS B.V. (NL) 2022-05-10 US disclosed
US-11306054-B2 Propanediol monoacetate mononitrate DSM IP ASSETS B.V. (NL) 2022-04-19 US disclosed
EP-3965721-A1 TOPICAL COMPOSITIONS DSM IP Assets B.V. (NL) 2022-03-16 EP disclosed
US-11191772-B2 Use DSM IP ASSETS B.V. (NL) 2021-12-07 US disclosed
WO-2019007789-A1 TOPICAL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2019-01-10 WO disclosed
WO-2019007792-A1 TOPICAL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2019-01-10 WO disclosed
WO-2019007790-A1 NOVEL USE DSM IP ASSETS B.V. (NL) 2019-01-10 WO disclosed
WO-2019007791-A1 TOPICAL COMPOSITIONS DSM IP ASSETS B.V. (NL) 2019-01-10 WO disclosed
US-9980889-B2 Compositions comprising P-hydroxybenzylamine DSM IP ASSETS B.V. (NL) 2018-05-29 US disclosed
US-20170035668-A1 NOVEL COMPOSITIONS COMPRISING P-HYDROXYBENZYLAMINE DSM IP ASSETS BV (NL) 2017-02-09 US disclosed
US-20150208650-A1 NOVEL COMPOSITIONS COMPRISING P-HYDROXYBENZYLAMINE DSM IP ASSETS B.V. (NL) 2015-07-30 US disclosed
EP-1439751-A1 ANTIMICROBIALLY-TREATED FABRICS Kimberly-Clark Worldwide, Inc. (US) 2004-07-28 EP disclosed
WO-2003032726-A1 ANTIMICROBIALLY-TREATED FABRICS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-04-24 WO disclosed
EP-0102695-B1 IMPROVED DENTIFRICE PREPARATIONS COMPRISING CALCINED KAOLIN ABRASIVES INDIANA UNIVERSITY FOUNDATION (US) 1990-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11306054-B2 Propanediol monoacetate mononitrate DERA, PHGDH, PGD SLC6A2 3178/4885SLC6A3 2707/4885CHRM2 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.